CHRISTINA ACKERMANN
CIK 1681871 · Please see remarks · last filed 2025-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.03M
Companies
5
Total Filings
44
Lifetime Open-Market Net
-$4.61M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$163.0K | 7 | 2025-10-08 |
| CALC | Director | 1,429 | $0.87 | $1.2K | $0 | 1 | 2023-03-27 |
| BLCO | Please see remarks | 146,677 | $15.08 | $2.21M | $0 | 3 | 2023-03-03 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| BHC | EVP AND GENERAL COUNSEL | 162,240 | $5.06 | $820.9K | -$4.45M | 23 | 2022-03-11 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-03 | — | Grant (A) | — | $0 | |
| 2017-01-10 | — | Grant (A) | +24,575 | $0 | |
| 2016-08-12 | — | Grant (A) | — | $0 | |
| 2016-08-10 | — | Grant (A) | +122,762 | $0 |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.